Inhibrx Biosciences INBX
NASDAQ INBX
$90.59 -0.02 (-0.02%)
At close: Nov 11, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Price to Earnings (2024 - 2025)

Updated

Inhibrx Biosciences' Price to Earnings came in at 0.12 for Q1 2025, down 11.0% from the prior quarter.

Analysis

Inhibrx Biosciences (INBX) Price to Earnings (2024 - 2025) Analysis & Trends

For FY2024, Inhibrx Biosciences' Price to Earnings was 0.13.

  • Business Quant data shows INBX's Price to Earnings at 0.13 (Q4 2024), 0.14 (Q3 2024) and 0.13 (Q2 2024) in the three quarters before Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 0.12
Dec 31, 2024 0.13
Sep 30, 2024 0.14
Jun 30, 2024 0.13
API Access

Inhibrx Biosciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=INBX&period=max&api_key=YOUR_API_KEY